Bourdette D - Search Results

1

Lipoic acid in multiple sclerosis: a pilot study.

Yadav V, Marracci G, Lovera J, Woodward W, Bogardus K, Marquardt W, Shinto L, Morris C, Bourdette D. Yadav V, et al. Among authors: bourdette d. Mult Scler. 2005 Apr;11(2):159-65. doi: 10.1191/1352458505ms1143oa. Mult Scler. 2005. PMID: 15794388 Clinical Trial.

2

Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.

Bourdette DN, Whitham RH, Chou YK, Morrison WJ, Atherton J, Kenny C, Liefeld D, Hashim GA, Offner H, Vandenbark AA. Bourdette DN, et al. J Immunol. 1994 Mar 1;152(5):2510-9. J Immunol. 1994. PMID: 7510746 Clinical Trial.

3

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis.

Marracci GH, Jones RE, McKeon GP, Bourdette DN. Marracci GH, et al. J Neuroimmunol. 2002 Oct;131(1-2):104-14. doi: 10.1016/s0165-5728(02)00269-2. J Neuroimmunol. 2002. PMID: 12458042

4

Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis.

Marracci GH, McKeon GP, Marquardt WE, Winter RW, Riscoe MK, Bourdette DN. Marracci GH, et al. J Neurosci Res. 2004 Nov 1;78(3):362-70. doi: 10.1002/jnr.20255. J Neurosci Res. 2004. PMID: 15389837

5

Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths.

Shinto L, Calabrese C, Morris C, Sinsheimer S, Bourdette D. Shinto L, et al. Among authors: bourdette d. J Altern Complement Med. 2004 Oct;10(5):891-7. doi: 10.1089/acm.2004.10.891. J Altern Complement Med. 2004. PMID: 15650479

6

A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis.

Bourdette DN, Edmonds E, Smith C, Bowen JD, Guttmann CR, Nagy ZP, Simon J, Whitham R, Lovera J, Yadav V, Mass M, Spencer L, Culbertson N, Bartholomew RM, Theofan G, Milano J, Offner H, Vandenbark AA. Bourdette DN, et al. Mult Scler. 2005 Oct;11(5):552-61. doi: 10.1191/1352458505ms1225oa. Mult Scler. 2005. PMID: 16193893 Clinical Trial.

7

The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis.

Shinto L, Yadav V, Morris C, Lapidus JA, Senders A, Bourdette D. Shinto L, et al. Among authors: bourdette d. Complement Ther Med. 2005 Dec;13(4):264-72. doi: 10.1016/j.ctim.2005.07.007. Epub 2005 Sep 12. Complement Ther Med. 2005. PMID: 16338197

8

Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis.

Shinto L, Yadav V, Morris C, Lapidus JA, Senders A, Bourdette D. Shinto L, et al. Among authors: bourdette d. Mult Scler. 2006 Feb;12(1):94-100. doi: 10.1191/1352458506ms1230oa. Mult Scler. 2006. PMID: 16459725

9

Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck).

Marracci GH, Marquardt WE, Strehlow A, McKeon GP, Gross J, Buck DC, Kozell LB, Bourdette DN. Marracci GH, et al. Biochem Biophys Res Commun. 2006 Jun 9;344(3):963-71. doi: 10.1016/j.bbrc.2006.03.172. Epub 2006 Apr 5. Biochem Biophys Res Commun. 2006. PMID: 16631599

10

Complementary and alternative medicine: is there a role in multiple sclerosis?

Yadav V, Bourdette D. Yadav V, et al. Among authors: bourdette d. Curr Neurol Neurosci Rep. 2006 May;6(3):259-67. doi: 10.1007/s11910-006-0014-y. Curr Neurol Neurosci Rep. 2006. PMID: 16635436 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters